Schedule a call →

<p>Interview fractional leaders this week for <strong>free</strong>!</p>

Corbus Pharmaceuticals is dedicated to developing therapies for cancer and obesity through cutting-edge research and compassionate care. Explore our pipeline of investigational treatments aimed at improving patient outcomes and quality of life.

Corbus Pharma Icon

Corbus Pharma is a leading pharmaceutical brand dedicated to advancing healthcare through innovative scientific approaches. Committed to helping people overcome serious illnesses, Corbus Pharma specializes in well-understood biological pathways. Their extensive pipeline includes two distinct oncology treatments with varying risk profiles. They develop next-generation Nectin-4 Antibody Drug Conjugates (ADC) as well as monoclonal antibodies targeting integrins to inhibit TGFβ activation. Corbus Pharma's team consists of high-achieving, creative, and passionate individuals who strive to make a difference in patients' lives. They offer various open positions for talented professionals looking to join their unique team. As an investor-friendly company, Corbus Pharma provides comprehensive investor relations information, including financial results, stock data, SEC filings, and analyst coverage. Stay updated on the latest news and breakthroughs by signing up for their email alerts. Corbus Pharma is dedicated to connecting innovation with purpose, transforming the landscape of healthcare.

Corbus Pharma

Chemical Industry

Heavy Industry and Engineering

var(--font-body)

Bebas Neue Pro W01

youtube

twitter

linkedin

facebook

Corbus Pharma Logo

Corbus is an oncology and obesity company committed to helping people defeat serious illness by bringing innovative scientific approaches to well understood biological pathways. Corbus’ internal development pipeline includes CRB-701, a next generation antibody drug conjugate (ADC) that targets the expression of Nectin 4-on cancer cells to release a cytotoxic payload and CRB-601, and anti-integrin monoclonal antibody which blocks the activation of TGFß expressed on cancer cells. Additionally, we are developing a cannabinoid receptor-1 (CB-1) inverse agonist as potential treatment for obesity. Corbus is headquarters in Norwood, Massachusetts. For more information on Corbus, visit corbuspharma.com. Connect with us on Twitter, LinkedIn and Facebook.

The Chief Business Officer will serve as the company’s senior executive responsible for business development and strategic transactions. The Chief Business Officer will be a trusted strategic partner to the CEO and senior leadership team, with deep experience in relationship building, defining BD strategy, driving pipeline value through BD initiatives, deal execution and high-stakes negotiations with global pharmaceutical partners and others in the biotech industry.

Considering candidates based locally to Boston area hybrid or New England/New York based candidates willing to travel to Norwood, Ma at least one day per week. Open to fulltime employee role or fractional role.

**Key Responsibilities:**

- Define and lead the company’s business development strategy, aligned with clinical development priorities and pre-commercial objectives.
- Partner with the CEO and executive team to determine optimal value-creation pathways for the pipeline
- Lead all BD activities, working with Corbus’ Alliance Manager, as applicable.
- Identify, engage, and cultivate relationships with senior executives at pharmaceutical and biotechnology companies.
- Own and execute end-to-end BD operational activities, including:
  - Tracking strategic relationships and interactions
  - Identifying clear strategic fit with target partners
  - Data room preparation and due diligence leadership
  - Valuation and deal structuring
  - Negotiation of term sheets and definitive agreements
- Prepare and present board-level strategic analyses, valuation frameworks, and transaction recommendations.
- Evaluate external assets, platforms, or technologies that complement the company’s obesity and oncology programs.
- Maintain real-time awareness of competitive landscape in obesity and oncology.
- Demonstrate executive-level skill in influencing, aligning, and motivating stakeholders, using strong interpersonal judgment.
- Active member of the senior leadership team.

**Qualifications:**

- 15+ years of experience in business development, corporate development, or strategy within biotech or pharmaceutical companies.  Experience should include senior leadership roles.
- Demonstrated success leading in-licensing, out-licensing, partnerships, and/or strategic M&A transactions and deep understanding of clinical development, regulatory pathways, and commercialization considerations.
- Direct experience in oncology. Obesity/metabolic experience is a bonus.
- Proven ability to engage at the CEO, Board, and C-suite level both internally and externally.
- Strong financial and valuation expertise, with a track record of negotiating complex, high-value agreements.
- Bachelor’s degree required; advanced degree (PhD, MD, PharmD, MBA) preferred.

Corbus Pharma

About Corbus Pharma

Jobs

Past roles

About this page